Jana urges Cooper to replace CEO, explore asset sales after performance setbacks

By Reuters News

Sept 18 (Reuters) - Activist investor Jana Partners on Friday urged Cooper Companies COO.O to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighed on the medical device maker's market value.

Cooper had lowered its annual forecasts last week and ended a review of options for its CooperSurgical unit without a sale.


Here are more details:

  • Jana asked Cooper to engage potential buyers for its contact lens unit, CooperVision, and consider a sale of fertility and medical device businesses within its CooperSurgical unit.

  • Cooper did not immediately respond to a Reuters request for comment.

  • The activist investor owns about 3.58 million shares, or 1.8% stake, in Cooper, according to its latest regulatory filing.‌

  • JANA is also calling for a new board chair and the addition of directors with expertise to strengthen oversight of the company.

  • Jana urged Cooper to link executive pay more closely to performance to boost accountability.

  • It also criticized Cooper's handling of excess inventory held by customers of CooperVision.

  • Jana said Cooper's shares have lagged peers and trade at a discount to comparable companies.

  • Shares have fallen about 21% over the past 12 months, compared with gains of about 19% for Becton Dickinson and 61% for Integer Holdings and a decline of about 17% for Alcon, according to data compiled by LSEG.

  • The investor also urged Cooper to hire an outside adviser to identify manufacturing and supply-chain cost savings at CooperVision.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.